Head-to-head · WeighScore
NativeMed vs PepHaūs
The verdict
PepHaūs takes it — 82.7/100 to 62.7/100.
PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Verified and nationwide, but priced in the upper-mid band ($152/$246).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NativeMed | PepHaūs |
|---|---|---|
| WeighScore | 62.7/100 | 82.7/100 |
| Grade | C | B− |
| Scorecard rank | #292 | #28 |
| Semaglutide | $149/mo (promotional rate, compounded) | $152/mo |
| Tirzepatide | $183/mo (promotional rate, compounded) | $246/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #292 · C
FDAWarning letter issued to NativeMed LLC dba NativeMed in June 2026. See the FDA warning-letter database.
Strengths
- LegitScript Certified (verifiable in the footer)
- Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
- Online questionnaire intake, with a live visit added when state law requires it
Where it loses points
- Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
- States served aren't listed publicly
- Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate
- FDA issued NativeMed LLC dba NativeMed a warning letter in June 2026; the letter is public in FDA's warning-letter database
Graded #28 · B−
Strengths
- LegitScript-verified, all 50 states
- Both molecules
- Transparent listed pricing
Where it loses points
- Upper-mid pricing ($152/$246)
- Injection-only
- Monitoring detail limited
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.